Related by context. All words. (Click for frequent words.) 61 MEK inhibitors 61 generation HCV nucleotide 61 Anticalin 61 HIV integrase inhibitors 61 epothilone 61 PDE4 inhibitor 59 MAXY VII 59 preclinical compounds 59 proprietary phage display 59 outlicensing 58 Synavive ™ 58 Pimavanserin 58 apricitabine ATC 58 Nanobody ® 58 orally bioavailable 58 Kosan dependence 58 PORxin TM 57 preclinical 57 therapeutic monoclonal antibody 57 Insegia 57 CCR9 antagonist 57 Fc engineered 57 seliciclib CYC# 57 ghrelin antagonist 57 romazarit 57 vosaroxin 57 Chimigen TM 57 JAK inhibitors 57 NTDDS 57 JAK3 57 Mersana 57 AMPK activators 57 allosteric modulator 57 Shigamabs ® 57 XL# XL# 57 targeted radiotherapeutic 57 developing TB4 56 HCV protease inhibitor 56 AEG# 56 dAb 56 antisense drug 56 JAK inhibitor 56 HuLuc# 56 metaglidasen 56 Panzem R NCD 56 HCV protease inhibitors 56 Archexin 56 QuatRx 56 pradefovir 56 MEK inhibitor 56 peptide therapeutics 56 glucokinase activator 56 TBC# 56 Tyzeka Sebivo 56 antisense drugs 56 rxRNA 56 siRNAs targeting 56 ONCONASE R 56 prostone 56 nucleoside 56 Inotek 56 GPR# agonist 56 CB2 selective 56 volociximab 55 VitiGam 55 Nanobodies 55 XmAb ® 55 Cetrorelix 55 SAR# [002] 55 anti CD3 monoclonal 55 deforolimus 55 ChemBridge 55 OMP #M# 55 synthetic retinoid 55 BCR ABL inhibitors 55 IAP inhibitors 55 nicotinic alpha 7 55 hepatitis C protease inhibitor 55 bardoxolone 55 nitric oxide donating prostaglandin 55 ViroChem 55 IND enabling 55 anticancer compound 55 JAK2 inhibitor 55 Factor VIIa 55 elotuzumab 55 investigational compounds 55 Virium 55 CDP# 55 IMA# 55 Nanobody 55 Ophthotech 55 Intellikine 55 Guanilib 55 Gag polymorphisms 55 ularitide 55 XmAb 55 CORT # 55 HIV maturation inhibition 55 DiaPep# 55 ZFP Therapeutics 55 TG# [003] 55 mSEPT9 biomarker 55 isoform selective 55 Celator 54 HIV integrase inhibitor 54 nucleoside tide 54 ulimorelin 54 CINOD 54 Angioblast 54 Kinase inhibitors 54 PRT# 54 Taligen 54 Eximias 54 ErbB3 HER3 54 IGN# 54 selective androgen receptor modulator 54 Cytochroma 54 HCV nucleoside 54 Mipomersen 54 Hsp# inhibition 54 Tyrima 54 atacicept 54 TOCOSOL Paclitaxel 54 ALN PCS 54 ALN TTR# 54 UltiMAb 54 sodium glucose transporter 54 Isis antisense 54 Bicifadine 54 XL# XL# XL# XL# 54 ibudilast 54 anticancer therapeutics 54 UVIDEM 54 Zolinza 54 PGL# 54 XmAb# 54 PSN# [002] 54 entinostat 54 daclizumab 54 HCV polymerase 54 OGeS 54 oral prodrug 54 elvucitabine 54 CRTH2 54 S#P# 54 faropenem 54 Prodarsan ® 54 OXIGON TM 54 tiapamil 54 outlicense 54 RGB # 54 Inotek Pharmaceuticals Corporation 54 RELOVAIR ™ 54 THR beta agonist 54 SERMs 54 NXL# 53 immunotherapeutic vaccine 53 OHR/AVR# 53 OncoVEX GM CSF 53 leading oral taxane 53 eniluracil 53 R#/MEM # 53 HIV protease inhibitor 53 additional purine nucleotide 53 Marqibo TM 53 Maxy G# 53 delta opioid receptor 53 Aganocide 53 Fleximer 53 HepeX B 53 fusion inhibitor 53 EndoTAG TM -1 53 GFT# 53 BCX# 53 MAXY G# 53 danoprevir 53 Micromet BiTE 53 FOLOTYN ® 53 Prednisporin TM 53 RNAi therapeutic 53 Nanobody R 53 PHX# 53 orally administered inhibitor 53 Anticalin R 53 IMC #B 53 Technosphere Insulin 53 ESBA# 53 renin inhibitors 53 orally dosed 53 kinase inhibitors 53 EndoTAG 53 Adnectin 53 TKM ApoB 53 CYT# potent vascular disrupting 53 Catabasis 53 AQ4N 53 XL# XL# XL# 53 Solazed TM 53 recombinant factor VIIa 53 forodesine 53 KNS # 53 ionotropic glutamate receptor antagonists 53 Targeted Immunotherapy 53 RhuDex ® 53 pexiganan 53 Charlesson 53 Phase 2b clinical trials 53 hematologic oncology 53 RNAi therapeutic targeting PCSK9 53 Sym# 53 MKC# MKC# PP 53 HyACT 53 OncoMed 53 Syncria 53 Cathepsin S 53 CTA# 53 IND submission 53 forodesine hydrochloride 53 integrase inhibitor 53 celgosivir 53 Hsp# inhibitors 53 MAXY alpha 53 ESTRASORB 53 commercialize elagolix 53 therapeutic peptide 53 TRIOLEX HE# 53 ISIS # 53 outlicensed 53 NNR Therapeutics 53 Endotis 53 BiTE 53 Relivar 53 Aplidin 53 PEGylated interferon 53 Phase IIb clinical trials 53 LNP formulations 53 liposomal formulation 52 oral PTH 52 molecular chaperone regulation 52 immunotherapeutic 52 PNP inhibitor 52 obatoclax 52 recombinant biopharmaceutical 52 Nasulin 52 CRLX# 52 BXT # 52 Apoptone 52 immatics 52 targeting PCSK9 52 Aerovance 52 LFRP 52 Adenosine Therapeutics 52 Sopherion 52 betrixaban 52 adrenergic regulation 52 Accelerated Intelligent 52 Stapled Peptide 52 TLR9 agonist 52 GPCR targets 52 mGluR5 antagonists 52 DCCR 52 CobaCyte 52 ALN VSP 52 Hybridon 52 aptamer therapeutics 52 HGS ETR1 52 Anticalins 52 Myocet 52 HQK 52 Veronate 52 HuMax CD# 52 Enanta 52 fostamatinib 52 Epothilones 52 TRAIL receptor antibodies 52 A3 adenosine receptor 52 TLR agonists 52 OvaRex 52 URG# 52 Aegera 52 Symadex 52 oncolytic 52 therapeutic monoclonal antibodies 52 ALN TTR 52 FoldRx 52 Mpex 52 DXL# 52 Cellzome 52 NEUMUNE 52 selective androgen receptor modulators 52 Trophos 52 FivePrime 52 CR# vcMMAE 52 lomitapide 52 CCR2 52 midstage studies 52 atrasentan 52 CoLucid 52 PhaseBio 52 teplizumab 52 Dyax phage display 52 SuperAntibody 52 Caprion 52 cardio renal 52 SYGNIS 52 intranasal insulin product 52 Vilazodone 52 cathepsin K inhibitor 52 Daclizumab 52 Memryte 52 ATL# [002] 52 Targeted Chemotherapy 52 ALK inhibitors 52 Spiegelmer 52 Anaphore 52 R roscovitine 52 MDV# 52 SGLT inhibitors 52 Solazed 52 BEMA TM Fentanyl 52 Scancell 52 selective immunoproteasome inhibitor 52 highly selective endothelin 52 DeveloGen 52 Amigal 52 drug conjugate ADC 52 JAK2 inhibitors 52 Allovectin 7 52 CD# CEA 52 Annamycin 52 cabozantinib 52 ChronVac C R 52 Trofex 52 Viventia 52 PsychoGenics 52 HEPLISAV ™ 52 alvespimycin 52 induced angioedema 52 cancer immunotherapies 52 Presents Preclinical 52 HGS# 52 Cerimon 52 GRN# 52 interferon lambda 52 NEUGENE R 52 EvaMist TM 52 LHRH antagonist 52 Canvaxin TM 52 L BLP# 52 EGS# 52 HuCAL antibodies 52 Numax 52 ESBATech 52 Galenea 52 Phase IIa clinical trials 52 Phase IIa trials 52 inlicensing 52 siRNA therapeutic 52 MKC# MT 52 Azedra TM 52 HuCAL PLATINUM 52 Hsp# inhibitor 52 oncolytic virus therapies 52 L Annamycin 52 Shigamabs R 52 Anavex #-# 52 tezampanel NGX# 52 tranilast 52 Theratope 52 proteasome inhibitor 52 XL# [003] 52 Squalamine 52 beta secretase inhibitors 52 CCR5 antagonists 52 Itero 52 GV# [001] 52 Gemin X 51 JAK1 51 SECTA therapy 51 enzastaurin 51 romidepsin novel 51 nanoviricide drug 51 miRNA therapeutics 51 Albugon 51 HyperAcute 51 HCD# [002] 51 Dicer Substrate Technology 51 Src inhibitors 51 DermaVir Patch 51 Ostabolin C TM 51 NNRs 51 Etubics 51 Zacharon 51 Lupuzor 51 orally bioavailable mimics 51 therapeutic antibody 51 Onalta 51 CCR5 antagonist 51 EndoTAG TM 51 Quark Biotech 51 HCV polymerase inhibitors 51 MKC# 51 protein kinase inhibitor 51 P#X# antagonist 51 dacetuzumab 51 INT# [002] 51 PanGenetics 51 cannabinor 51 Ceflatonin R 51 polymerase inhibitors 51 otelixizumab 51 DU #b 51 Dapagliflozin 51 CRACM 51 SPC# [001] 51 systemic RNAi therapeutic 51 immune modulating 51 IMiDs R 51 ProLindac TM 51 ALN RSV program 51 Diamyd ® 51 topical anti infective 51 Lixivaptan 51 oral fludarabine 51 Valdoxan 51 CEQ# 51 TMC# [002] 51 BEXXAR 51 RNAi therapeutic targeting 51 siRNA therapeutics 51 SARMs 51 XL# anticancer compounds 51 enGene 51 Epanova 51 ART# 51 TH# [003] 51 Intraject 51 Vegenics 51 NOX E# 51 Neo Kidney Augment ™ 51 Viramidine 51 midstage trials 51 staphylococcal vaccine 51 GLPG# 51 AVN# [001] 51 IMiDs ® 51 sapacitabine 51 commercialize lorcaserin 51 SinuNase ™ 51 OvaRex R 51 bicifadine 51 AGS PSCA 51 PSN# [001] 51 OMJPI 51 crofelemer 51 PEG SN# 51 ARIKACE ™ 51 MET inhibitor 51 tubulin inhibitor 51 chronic HCV infection 51 Sphingomab 51 candidate CRLX# 51 MGCD# [001] 51 Epigenomics proprietary 51 Curaxin 51 pharmacological chaperone 51 PF # [001] 51 polymerase inhibitor 51 Cx# [002] 51 Radezolid 51 Anticalins R 51 Innovive Pharmaceuticals 51 Behcet uveitis 51 GSK '# 51 ASONEP 51 castrate resistant prostate cancer 51 Syntonix 51 inhaled liposomal ciprofloxacin 51 MorphoSys proprietary 51 ColorectAlert TM 51 Vaccinex 51 Xcytrin R 51 DPP4 inhibitor 51 Excaliard 51 ALS #-# 51 compound AEOL # 51 Aurora kinase inhibitor 51 personalized immunotherapy 51 Rotarix ® 51 Posiphen TM 51 Panzem R 51 stable nucleic acid 51 novel RNAi therapeutics 51 histone deacetylase HDAC inhibitors 51 DB# [003] 51 MorphoSys antibody 51 MCSP respectively 51 peptidomimetic 51 Desmoteplase 51 favorable pharmacokinetic profile 51 Potelligent Technology 51 humanized antibody 51 GED aPC 51 Enhanze Technology 51 DPX Survivac 51 SAR# [004] 51 DAVANAT R 51 ospemifene 51 VersaFilm 51 ASG 5ME 51 selective GR 51 LentiVector technology 51 lipid particle 51 lorvotuzumab mertansine 51 diabetes irritable bowel 51 CCX# 51 EOquin 51 MOR# 51 Locked Nucleic Acid 51 KSP inhibitor 51 urocortin 2 51 IMC #F# 51 Cempra 51 OncoVEX 51 immunotoxin 51 proteasome inhibitors 51 Proellex TM 51 ZK EPO 51 HCV nucleotide polymerase inhibitor 51 Nanobodies ® 51 Onalta ™ 51 Prodarsan R 51 Surfaxin LS 51 DOS# 51 ErbB3 51 nucleoside analogues 51 nucleoside analog 51 Stimuvax R 51 Curaxins 51 Epitomics 51 non nucleoside HCV 51 Angiocept 51 Alexza Staccato 51 iPSC technology 51 TOPIGEN 51 lumiliximab 51 ganetespib 51 HCV antiviral 51 Aegera Therapeutics 51 activate SIRT1 51 Enanta Pharmaceuticals 51 selective kinase inhibitor 51 gastro intestinal inflammation 51 PDE7 51 Omthera 51 ceftazidime 51 Exelixis compounds 51 oral talactoferrin 51 taxane chemotherapy 51 Drug Discovery AIDD 51 novel immunomodulatory 51 Urocortin 2 51 next generation URAT1 51 PREOS R 51 CB1 antagonists 51 highly selective adenosine 51 Aurexis 51 syndrome carcinoid syndrome 51 Pancreate 51 PI3K inhibitors 51 TACI Ig 51 Synavive 51 DGAT1 inhibitors 51 MVA BN R 51 Alnara 51 drug conjugate 51 AtuRNAi 51 LEX System 51 chimeric monoclonal antibody 51 eprotirome 50 antisense inhibitors 50 AERx iDMS 50 Akt inhibitor 50 platforms GVAX 50 mAb 50 muscarinic receptor agonist 50 molecular entities NMEs 50 Versartis 50 inhibit replication 50 RNA antagonists 50 transient receptor 50 CMV vaccine 50 Plicera 50 5 HT6 50 TPI ASM8 50 HCV nucleoside polymerase inhibitors 50 Azedra 50 tolevamer 50 novel anti infective 50 Ridaforolimus 50 belinostat 50 Inflazyme 50 Tolerx 50 Onco TCS 50 Numoda 50 Evoltra ® 50 ENMD # 50 ELND-#/AZD-# 50 Astex 50 Karo Bio 50 Alnylam #x# 50 neuroprotective properties 50 YONDELIS R 50 maturation inhibition 50 Supernus 50 Uvidem 50 oral salmon calcitonin 50 SIRT1 activators 50 TLR Therapeutics 50 HuMax CD4 50 HuCAL 50 investigational monoclonal antibody 50 DepoVax ™ 50 Preclinical studies suggest 50 PS# [001] 50 GLP toxicology studies 50 Vicriviroc 50 nucleotide analog polymerase inhibitor 50 PANVAC VF 50 ridaforolimus 50 lixivaptan 50 PRX # 50 SNT MC# 50 registrational trials 50 TRO# 50 molecular imaging radiopharmaceutical 50 preclinically 50 generation purine nucleoside 50 Nektar proprietary 50 Nasulin ™ 50 drug pipeline TAFA# 50 chemopreventive agent 50 PI3K inhibitor 50 small molecule tyrosine 50 epigenetic therapies 50 DNA methylation biomarkers 50 davalintide 50 InterfeRx TM 50 ARG# 50 hepatitis C HCV 50 Micromet proprietary BiTE 50 Trofex TM 50 IPL# 50 Prednisporin 50 CFTR inhibitors 50 recombinant polyclonal antibody 50 Neuraltus 50 selectively modulate 50 P#X# 50 Selective Electrochemical Tumor Ablation 50 Troxatyl 50 Zemiva TM 50 selective S#P# receptor agonist 50 HuCAL antibody 50 beta interferons 50 Ambrx 50 immunomodulatory therapy 50 inhaled AAT 50 MAb 50 Icatibant 50 apply Enhanze technology 50 PDE# inhibitors 50 Evolva 50 obatoclax GX# 50 lipid nanoparticle 50 Zosano 50 anticancer compounds 50 pan HDAC inhibitor 50 registrational trial 50 Biolipox 50 Xanafide 50 potent antiproliferative 50 Ozarelix 50 radiation sensitizer 50 melanocortin receptor 50 flu mAb 50 kinase inhibitor 50 CRD5 50 CCR5 inhibitor 50 Elvitegravir 50 Mesafem 50 VaxImmune 50 Asentar 50 XOMA 3AB 50 Amplimexon 50 androgen receptor antagonist 50 plasmid DNA vaccine 50 VEGF Trap 50 LymphoStat B TM 50 VentiRx 50 MultiStat 50 AN# novel 50 Nasulin TM 50 Exherin 50 elinogrel 50 Cerenis 50 Metallophile ™ Technology 50 Novartis NVS Snapshot Report 50 cardiometabolic 50 Spiegelmer ® 50 Phase 2b clinical 50 ASONEP TM 50 HspE7 50 Bendavia 50 torezolid 50 Delafloxacin 50 Oral NKTR 50 VitiGam TM 50 motexafin gadolinium Injection 50 PREOS 50 GKAs 50 therapeutic mAbs 50 undruggable targets 50 PARP inhibitors 50 AKT inhibitor 50 PF # [002] 50 registrational 50 Pertuzumab 50 recombinant plasma 50 phase IIb clinical 50 OvaRex ® MAb 50 aminocandin 50 Phase 2a clinical trials 50 RNA therapeutics 50 HepDirect 50 DNA RNA Medicines 50 basal insulin analogue 50 Tobira Therapeutics 50 mGluR4 PAM 50 Olaparib 50 EP #R 50 unique PER.C6 50 regorafenib 50 ImmunoGen TAP technology 50 Oglemilast 50 Aerosurf 50 YONDELIS 50 Addrenex 50 including eniluracil ADH 50 shRNA libraries 50 GAP #B# 50 AEGR 50 EDEMA3 50 TaiGen 50 Alocrest 50 blood clot dissolver 50 anti CD# antibodies 50 intranasal formulation 50 cardiometabolic disorders 50 Relypsa 50 Elagolix 50 OXi# 50 anti angiogenic agents 50 Hemopurifier ® 50 mGluR2 NAM 50 lintuzumab SGN 50 DepoBupivacaine TM 50 Serdaxin 50 cilengitide 50 CeNeRx 50 inflammatory autoimmune diseases 50 antifolates 50 anti amnesic 50 humanized antibodies 50 Kolltan 50 Proxinium TM 50 Apo AIMilano 50 nucleoside tide analogs 50 HCV polymerase inhibitor 50 AFFITOME R 50 novel anticancer 50 TRIOLEX TM HE# 50 PRAECIS 50 BioSeek 50 rNAPc2 50 NicVAX 50 RenaZorb 50 TLR8 agonist 50 nucleotide analog 50 small molecule 50 Zalbin 49 Pepducin 49 pediatric acute lymphoblastic 49 candidate ATHX 49 generation FBPase inhibitor 49 GnRH 49 elagolix 49 Hedgehog agonist 49 Thiovir 49 VivaGel TM 49 Atelvia 49 LigoCyte 49 Novolimus 49 allosteric modulation 49 Metabolex 49 ostarine 49 GVAX cancer 49 platinum chemotherapeutic 49 compound AEZS 49 Zybrestat 49 EVIZON TM squalamine lactate 49 KaloBios 49 indibulin 49 ELACYT 49 rheumatoid arthritis thrombocytopenia 49 IMC A# 49 small molecule glucokinase 49 IMPDH inhibitor 49 aleglitazar 49 Cobalamin 49 triphendiol 49 Luteinizing Hormone Releasing Hormone 49 HIV integrase 49 AFFiRiS 49 Pradefovir 49 phase IIb trial 49 midstage clinical 49 cleavable linker 49 droxidopa 49 Protexia R 49 humanized monoclonal antibody 49 adipiplon 49 tkRNAi technology 49 chemical entities NCEs 49 aldehyde dehydrogenase ALDH2 deficiency 49 Cephalon Oncology 49 Regado 49 NS5A 49 antimitotic 49 selective receptor agonist 49 Immunogen 49 OMP #R# 49 gefitinib Iressa 49 Onconase 49 hypoxia activated prodrug 49 druggable 49 Panzem 49 Antibody Drug Conjugate 49 vilazodone 49 Acetylon 49 Fc fusion protein 49 EyeGate 49 biobetter 49 5 HT6 antagonist 49 Alferon N 49 ABILIFY ® 49 stranded LNA 49 Aquinox 49 Cytolin R 49 vivo potency 49 Intarcia 49 vaccine GRNVAC1 49 immunological diseases 49 PI3K/mTOR 49 predictive biomarkers 49 SLx 49 Litx 49 PRTX 49 GATTEX teduglutide 49 Telatinib 49 Davanat 49 sapacitabine CYC# 49 Tesetaxel 49 generation URAT1 inhibitor 49 Cardioxyl 49 Cloretazine 49 Toraymyxin TM 49 clinically validated targets 49 AzaSite Plus 49 Protexia ® 49 panitumumab Vectibix 49 oncolytic virus 49 VIBATIV ™ 49 inhaled formulation 49 Menerba 49 Kosan motilin agonist 49 Peptimmune 49 bremelanotide 49 eligen R technology 49 CYT# vascular disrupting 49 subcutaneous immunoglobulin 49 Innate Pharma 49 KuDOS 49 Tumour Vascular Disrupting Agent 49 Anticalin ® 49 telaprevir VX 49 generation PNP inhibitor 49 relapsed leukemia 49 fesoterodine 49 renin inhibition 49 Lycera 49 HuMax TAC 49 compound KOS 49 nucleotide analogues 49 RLY# 49 NeuVax 49 radiotherapeutic 49 DsiRNA 49 farletuzumab 49 oral proteasome inhibitor 49 myasthenia gravis Huntington 49 immunotherapeutics 49 cholesteryl ester transfer 49 vitro diagnostics IVD 49 Aganocide ® 49 renin inhibitor 49 Personalized Immunotherapy 49 anti infective therapeutics 49 goserelin 49 Affilin ® 49 LHRH receptor positive 49 JAK3 inhibitor 49 Blinatumomab 49 antibody humanization 49 MicroDose 49 MSCRAMM R 49 delta isoform 49 Avastin adjuvant 49 alagebrium 49 Phase IIb trials 49 SonoLysis 49 ALN RSV# 49 EpiTherapeutics 49 HuMax 49 PEG Interferon lambda 49 Octreotide 49 immunotherapeutic approaches 49 LHRH antagonists 49 BioFocus 49 TRIOLEX ™ 49 Intravenous CP 49 MAbs 49 Alder Biopharmaceuticals 49 CB2 receptor selective 49 INCB# [001] 49 X Excite 49 cyclophilin inhibitors 49 Nasdaq RXII 49 telomerase inhibitor 49 rindopepimut 49 AdVac 49 Prestige Antibodies 49 purinergic receptors P#X# 49 ATL/TV# 49 tesetaxel 49 teduglutide 49 Hepatitis C Virus HCV 49 Elisabeth Lindner CEO 49 TOCOSOL 49 PNT# 49 methylnaltrexone 49 CD# antibody [001] 49 Triapine 49 Symphogen 49 E2F Decoy 49 nucleoside analogue 49 recombinant subunit vaccine 49 potency selectivity 49 Fleximer R 49 ViiV Healthcare 49 p# inhibitor 49 Relovair 49 HSP# inhibitor 49 TELINTRA R 49 Urocidin 49 Anacor 49 GeoVax vaccine 49 drug conjugates 49 oral ghrelin agonist 49 phase IIa clinical 49 Neurimmune 49 CoFactor 49 mertansine 49 Kevetrin ™ 49 sodium glucose cotransporter 49 pafuramidine 49 TKB# 49 topical dermatology 49 oral picoplatin 49 HuMax Inflam 49 cytomegalovirus infections 49 Semafore 49 pegylated interferons 49 EHT AGN 49 dextofisopam 49 selective estrogen receptor modulator 49 BMS # 49 virus HCV protease inhibitor